Subjects with other uncontrolled medical conditions, e.g. myocardial infarction, cerebrovascular accident, diabetes or hypertension.
Patients with arterial thrombotic events, such as cerebrovascular accident or myocardial infarction, within  months of enrollment
History of myocardial infarction or cerebrovascular accident within  months of enrollment date
A history of events such as myocardial infarction, cerebrovascular accident or acute hepatitis within  months of randomization or treatment of a major active infection within one month of randomization, or any other significant event that in the opinion of the Investigator would preclude protocol therapy.
Known history of cerebrovascular accident, myocardial infarction, or intracranial hemorrhage within  months of enrollment.
History of cerebrovascular accident, myocardial infarction or unstable angina within the previous  months before starting therapy
Clinically significant cardiomyopathy or cardiac complications, including recent myocardial infarction or cerebrovascular accident within one year, and/or unstable or uncontrolled angina
Patients with a known history of myocardial infarction or cerebrovascular accident are not eligible
Patients with a history of myocardial infarction, unstable angina, or cerebrovascular accident <  months prior to registration
Myocardial infarction or cerebrovascular accident within  months prior to study registration
History of documented myocardial infarction or cerebrovascular accident
Subject has history of severe/unstable angina, myocardial infarction or cerebrovascular accident within  months prior to the planned first dose of study drug.
Subject has history of severe/unstable angina, myocardial infarction or cerebrovascular accident within  months prior to the planned first dose of study drug.
Subject has history of severe/unstable angina, myocardial infarction or cerebrovascular accident within  months prior to the first dose of study drug.
History of myocardial infarction or cerebrovascular accident within  months of enrollment date.
Subject has history of severe/unstable angina, myocardial infarction, or cerebrovascular accident within  months prior to the first dose of study drug.
